Latest news with #HMSE
Yahoo
4 days ago
- Business
- Yahoo
Global Market Value Stocks Trading At Estimated Discounts
In recent weeks, global markets have experienced a mix of optimism and caution as trade policies and inflation trends continue to influence investor sentiment. While U.S. stocks saw gains amid trade negotiations, European markets are adjusting to potential rate cuts due to slowing inflation, and Asian equities reflect ongoing trade discussions with the U.S. In such a fluctuating environment, identifying undervalued stocks can be an appealing strategy for investors looking to capitalize on market inefficiencies. These stocks may offer potential value when trading at estimated discounts relative to their intrinsic worth, providing opportunities amidst broader economic uncertainties. Name Current Price Fair Value (Est) Discount (Est) USU Software (HMSE:OSP2) €25.79 €51.17 49.6% Sahara International Petrochemical (SASE:2310) SAR18.98 SAR37.74 49.7% MicroPort CardioFlow Medtech (SEHK:2160) HK$0.88 HK$1.75 49.7% Kanto Denka Kogyo (TSE:4047) ¥840.00 ¥1679.07 50% Heartland Group Holdings (NZSE:HGH) NZ$0.78 NZ$1.55 49.8% Good Will Instrument (TWSE:2423) NT$44.05 NT$87.37 49.6% Fuji (TSE:6134) ¥2240.50 ¥4455.77 49.7% DigiTouch (BIT:DGT) €1.83 €3.64 49.7% 3U Holding (XTRA:UUU) €1.495 €2.99 50% 123fahrschule (DB:123F) €4.24 €8.46 49.9% Click here to see the full list of 509 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. Overview: China National Software & Service Company Limited operates as a software company in China with a market capitalization of CN¥37.91 billion. Operations: The company generates revenue primarily from its Software Service Business, amounting to CN¥5.14 billion. Estimated Discount To Fair Value: 19.6% China National Software & Service is trading at CN¥44.97, below its estimated fair value of CN¥55.95, suggesting it is undervalued by 19.6%. Despite a recent decline in quarterly revenue to CN¥640.5 million from the previous year's CN¥702.71 million, the company shows promising growth potential with earnings expected to grow significantly annually and become profitable within three years, outperforming average market growth rates despite a forecasted low return on equity of 9.4%. Our expertly prepared growth report on China National Software & Service implies its future financial outlook may be stronger than recent results. Delve into the full analysis health report here for a deeper understanding of China National Software & Service. Overview: Chung-Hsin Electric and Machinery Manufacturing Corp. operates in the electric and machinery manufacturing sector with a market cap of NT$76.33 billion. Operations: The company's revenue is derived from three main segments: Motor Energy Business contributing NT$19.28 billion, Service Business generating NT$5.17 billion, and Engineering and Other providing NT$3.21 billion. Estimated Discount To Fair Value: 21.7% Chung-Hsin Electric and Machinery Manufacturing is trading at NT$159, below its estimated fair value of NT$203.12, indicating it is undervalued by over 20%. Despite a slight decline in quarterly net income to TWD 878.6 million from TWD 953.24 million the previous year, the company demonstrates strong growth prospects with earnings forecasted to grow significantly annually, surpassing Taiwan's market average while maintaining reliable dividend payments. The growth report we've compiled suggests that Chung-Hsin Electric and Machinery Manufacturing's future prospects could be on the up. Take a closer look at Chung-Hsin Electric and Machinery Manufacturing's balance sheet health here in our report. Overview: Rheinmetall AG is a global provider of mobility and security technologies, with a market cap of €85.66 billion. Operations: The company's revenue segments include Power Systems (€2.00 billion), Vehicle Systems (€4.25 billion), Electronic Solutions (€1.87 billion), and Weapon and Ammunition (€3.02 billion). Estimated Discount To Fair Value: 38% Rheinmetall is trading at €1,882, significantly below its estimated fair value of €3,035.4. Recent strategic partnerships and strong financial performance highlight growth potential. First-quarter sales surged to €2.31 billion from €1.58 billion a year ago, with net income rising to €84 million from €48 million. The company's earnings are forecasted to grow annually by 34%, outpacing the German market average of 16.4%, underscoring its undervaluation based on cash flows. Insights from our recent growth report point to a promising forecast for Rheinmetall's business outlook. Click here to discover the nuances of Rheinmetall with our detailed financial health report. Click this link to deep-dive into the 509 companies within our Undervalued Global Stocks Based On Cash Flows screener. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:600536 TWSE:1513 and XTRA:RHM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Hindu
29-05-2025
- Health
- The Hindu
Urban dementia screening study highlights gaps in awareness and early detection
An urban dementia screening study, involving 716 older adults from upper socio-economic backgrounds across apartment complexes in Bengaluru, has found that family members and the elderly often miss early signs of cognitive decline. The study conducted by Dementia India Alliance (DIA), an NGO promoting dementia care in the country, in association with Athulya Senior Care, has found that stigma continues to prevent timely screening, even in educated communities. This initiative comes in the wake of growing evidence of the rising prevalence of dementia in India. The Longitudinal Aging Study in India - Diagnostic Assessment of Dementia (LASI-DAD) has estimated that over 7.4% of Indians aged 60 and above may be living with dementia, with nearly 90% remaining undiagnosed owing to a lack of awareness, stigma, and access to trained professionals. Findings of study Giving details of the findings, Ramani Sundaram, executive director of DIA, told presspersons on Thursday that among 591 elders aged 60-plus, 12.2% of the individuals were identified with cognitive impairment through HMSE (Hindi Mental State Examination) score of ≤23. While 29.2% men and 25% women had at least one vascular comorbidity, 30.6% men and 26.4% women had either hearing or vision impairment. These findings highlight the need to address vascular risk factors such as diabetes, hypertension, and sensory impairments, all of which were commonly observed among participants, she said. The study found that family members of 56.9% individuals screened failed to recognise early signs of cognitive decline, underscoring how stigma continues to delay timely screening even in educated communities. An additional 72 participants had scored 24-26 in HMSE, 59.7% amongst them male. These individuals are considered a vulnerable population and will be followed up with individual and family education to encourage further assessment, she said. Among 79 individuals aged between 50 and 59, 11.4% had cognitive impairment, of which 66.7% individuals had at least one vascular or sensory comorbidity. This early-onset trend further emphasises the need for preventive strategies and early interventions, even among younger older adults. Further assessment Radha S. Murthy, DIA president, said individuals identified with cognitive impairment and those belonging to the vulnerable group will be referred and followed up through DemClinic – the free online memory clinic – for further assessment and personalised risk reduction counselling. The study findings raise urgent questions about preparedness, access to assessment, and culturally appropriate tools for early detection in India's rapidly ageing population. In addition, the study brings to light the need for more nuanced public education and targeted outreach, especially in urban settings where denial and fear of diagnosis often deter participation, she said. 'The data reinforces what we see in the field — awareness is still low, even among well-educated families. We need multi-layered approaches to ensure people are assessed early and guided to appropriate care and support,' Dr. Murthy added.
Yahoo
03-05-2025
- Business
- Yahoo
Calculating The Fair Value Of Vantage Towers AG (HMSE:VTWR)
Vantage Towers' estimated fair value is €43.88 based on Dividend Discount Model Vantage Towers' €37.20 share price indicates it is trading at similar levels as its fair value estimate When compared to theindustry average discount to fair value of 73%, Vantage Towers' competitors seem to be trading at a greater discount Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Vantage Towers AG (HMSE:VTWR) as an investment opportunity by projecting its future cash flows and then discounting them to today's value. We will use the Discounted Cash Flow (DCF) model on this occasion. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine. Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. We've discovered 2 warning signs about Vantage Towers. View them for free. As Vantage Towers operates in the telecom sector, we need to calculate the intrinsic value slightly differently. Instead of using free cash flows, which are hard to estimate and often not reported by analysts in this industry, dividends per share (DPS) payments are used. This often underestimates the value of a stock, but it can still be good as a comparison to competitors. The 'Gordon Growth Model' is used, which simply assumes that dividend payments will continue to increase at a sustainable growth rate forever. For a number of reasons a very conservative growth rate is used that cannot exceed that of a company's Gross Domestic Product (GDP). In this case we used the 5-year average of the 10-year government bond yield (1.1%). The expected dividend per share is then discounted to today's value at a cost of equity of 4.6%. Compared to the current share price of €37.2, the company appears about fair value at a 15% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate) = €1.5 / (4.6% – 1.1%) = €43.9 Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Vantage Towers as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 4.6%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. See our latest analysis for Vantage Towers Strength No major strengths identified for VTWR. Weakness Dividend is low compared to the top 25% of dividend payers in the Telecom market. Opportunity Current share price is below our estimate of fair value. Lack of analyst coverage makes it difficult to determine VTWR's earnings prospects. Threat Total liabilities exceed total assets, which raises the risk of financial distress. Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. DCF models are not the be-all and end-all of investment valuation. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Vantage Towers, we've put together three additional items you should further examine: Risks: As an example, we've found 2 warning signs for Vantage Towers (1 shouldn't be ignored!) that you need to consider before investing here. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! Other Top Analyst Picks: Interested to see what the analysts are thinking? Take a look at our interactive list of analysts' top stock picks to find out what they feel might have an attractive future outlook! PS. Simply Wall St updates its DCF calculation for every German stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
22-04-2025
- Business
- Yahoo
Should You Investigate Stemmer Imaging AG (HMSE:S9I) At €55.80?
Stemmer Imaging AG (HMSE:S9I), is not the largest company out there, but it received a lot of attention from a substantial price movement on the HMSE over the last few months, increasing to €58.00 at one point, and dropping to the lows of €52.20. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Stemmer Imaging's current trading price of €55.80 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Stemmer Imaging's outlook and value based on the most recent financial data to see if there are any catalysts for a price change. We've discovered 1 warning sign about Stemmer Imaging. View them for free. Stemmer Imaging is currently expensive based on our price multiple model, where we look at the company's price-to-earnings ratio in comparison to the industry average. We've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows. The stock's ratio of 44.39x is currently well-above the industry average of 14.42x, meaning that it is trading at a more expensive price relative to its peers. But, is there another opportunity to buy low in the future? Since Stemmer Imaging's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market. View our latest analysis for Stemmer Imaging Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With revenues expected to grow by 34% over the next couple of years, the future seems bright for Stemmer Imaging. If the level of expenses is able to be maintained, it looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. Are you a shareholder? S9I's optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. At this current price, shareholders may be asking a different question – should I sell? If you believe S9I should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed. Are you a potential investor? If you've been keeping tabs on S9I for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for S9I, which means it's worth diving deeper into other factors in order to take advantage of the next price drop. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. For example - Stemmer Imaging has 1 warning sign we think you should be aware of. If you are no longer interested in Stemmer Imaging, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
21-04-2025
- Business
- Yahoo
Halloren Schokoladenfabrik's (HMSE:H2RB) Returns On Capital Are Heading Higher
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. So on that note, Halloren Schokoladenfabrik (HMSE:H2RB) looks quite promising in regards to its trends of return on capital. Our free stock report includes 2 warning signs investors should be aware of before investing in Halloren Schokoladenfabrik. Read for free now. For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. Analysts use this formula to calculate it for Halloren Schokoladenfabrik: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.0088 = €298k ÷ (€35m - €1.8m) (Based on the trailing twelve months to December 2023). Thus, Halloren Schokoladenfabrik has an ROCE of 0.9%. In absolute terms, that's a low return and it also under-performs the Food industry average of 9.2%. Check out our latest analysis for Halloren Schokoladenfabrik Historical performance is a great place to start when researching a stock so above you can see the gauge for Halloren Schokoladenfabrik's ROCE against it's prior returns. If you'd like to look at how Halloren Schokoladenfabrik has performed in the past in other metrics, you can view this free graph of Halloren Schokoladenfabrik's past earnings, revenue and cash flow. We're delighted to see that Halloren Schokoladenfabrik is reaping rewards from its investments and has now broken into profitability. The company was generating losses five years ago, but now it's turned around, earning 0.9% which is no doubt a relief for some early shareholders. At first glance, it seems the business is getting more proficient at generating returns, because over the same period, the amount of capital employed has reduced by 32%. The reduction could indicate that the company is selling some assets, and considering returns are up, they appear to be selling the right ones. From what we've seen above, Halloren Schokoladenfabrik has managed to increase it's returns on capital all the while reducing it's capital base. Since the stock has only returned 39% to shareholders over the last five years, the promising fundamentals may not be recognized yet by investors. Given that, we'd look further into this stock in case it has more traits that could make it multiply in the long term. One final note, you should learn about the 2 warning signs we've spotted with Halloren Schokoladenfabrik (including 1 which makes us a bit uncomfortable) . If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
